[
  {
    "ts": "2025-09-30T20:15:00+00:00",
    "headline": "IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025",
    "summary": "RESEARCH TRIANGLE PARK, N.C., September 30, 2025--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accomp",
    "url": "https://finance.yahoo.com/news/iqvia-announce-third-quarter-2025-201500711.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8586bc0a-8889-38fa-baf4-cd8609df1061",
      "content": {
        "id": "8586bc0a-8889-38fa-baf4-cd8609df1061",
        "contentType": "STORY",
        "title": "IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025",
        "description": "",
        "summary": "RESEARCH TRIANGLE PARK, N.C., September 30, 2025--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accomp",
        "pubDate": "2025-09-30T20:15:00Z",
        "displayTime": "2025-09-30T20:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/83996984fbd1d16accfb619c475dcc03",
          "originalWidth": 546,
          "originalHeight": 209,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6j0g7KbUULFJsLJSkW9T0Q--~B/aD0yMDk7dz01NDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/83996984fbd1d16accfb619c475dcc03.cf.webp",
              "width": 546,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7eJQpATjZhBteDb05ydX.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/83996984fbd1d16accfb619c475dcc03.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-announce-third-quarter-2025-201500711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-announce-third-quarter-2025-201500711.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T20:05:40+00:00",
    "headline": "Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is advancing its “Most Favored Nation” initiative, which aims to lower prescription drug costs for Americans. This policy would tie the prices of medications in the U.S. to the lowest costs paid by other wealthy nations. As part of this push, Pfizer has reportedly entered into an agreement to voluntarily sel",
    "url": "https://finance.yahoo.com/news/masimo-integra-lifesciences-conmed-iqvia-200540531.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a74a1415-2a4a-3fd8-9012-8645b4398b45",
      "content": {
        "id": "a74a1415-2a4a-3fd8-9012-8645b4398b45",
        "contentType": "STORY",
        "title": "Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is advancing its “Most Favored Nation” initiative, which aims to lower prescription drug costs for Americans. This policy would tie the prices of medications in the U.S. to the lowest costs paid by other wealthy nations. As part of this push, Pfizer has reportedly entered into an agreement to voluntarily sel",
        "pubDate": "2025-09-30T20:05:40Z",
        "displayTime": "2025-09-30T20:05:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/d5c4fd0f3134073f515b00835af29c87",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "MASI Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0XAhorRP0BUACQIaeuZ10Q--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/d5c4fd0f3134073f515b00835af29c87.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eRTjdOoOTTe6MSWKHoI0Kw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/d5c4fd0f3134073f515b00835af29c87.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/masimo-integra-lifesciences-conmed-iqvia-200540531.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/masimo-integra-lifesciences-conmed-iqvia-200540531.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "CNMD"
            },
            {
              "symbol": "MASI"
            },
            {
              "symbol": "IART"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]